Method comparison of plasma and CSF GFAP immunoassays across multiple platformsBurak Arslanon September 1, 2025 at 10:00 am
Clin Chem Lab Med. 2025 Sep 2. doi: 10.1515/cclm-2025-0667. Online ahead of print. ABSTRACT OBJECTIVES: Glial fibrillary acidic protein (GFAP) is a biomarker of astrocytic activation associated with neurodegenerative diseases, neuroinflammatory disorders, and traumatic brain injury. However, the lack of standardized methods for quantifying GFAP across different immunoassay platforms poses challenges for its clinical implementation. … Read more
